Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States von Hussain, Arif, Jiang, Shan, Varghese, Della, Appukkuttan, Sreevalsa, Kebede, Nehemiah, Gnanasakthy, Kajan, Macahilig, Cynthia, Waldeck, Reg, Corman, Shelby

Volltext

A review of patient-reported outcome assessments in registration trials of FDA-approved new oncology drugs (2014–2018) von Gnanasakthy, Ari, Russo, Jon, Gnanasakthy, Kajan, Harris, Nimanee, Castro, Colleen

Volltext

Frequency, management, and resource use of adverse events (AEs) in nonmetastatic castrate-resistant prostate cancer (nmCRPC) patients receiving apalutamide or enzalutamide: A real-... von Jiang, Shan, Varghese, Della, Appukkuttan, Sreevalsa, Corman, Shelby, Kebede, Nehemiah, Gnanasakthy, Kajan, Macahilig, Cynthia, Waldeck, A. Reginald, Hussain, Arif

Volltext

Measuring “What Matters Most™” to individuals living with Alzheimer’s disease and care partners: A conceptual model of Alzheimer’s Disease von Romano, Carla (DeMuro), Slota, Christina, Bratlee‐Whitaker, Emily, Edwards, Teresa, Herring, William L, McLeod, Lori, Callahan, Leigh F, Bullok, Kristin E, Raimundo, Karina, Taylor, James, Taylor, Geri, Kremer, Ian N., Lappin, Debra, Frangiosa, Theresa, Goss, Diana, Gnanasakthy, Kajan, Comer, Meryl, Monks, Doreen, Paulsen, Russ, Hartry, Ann, DiBenedetti, Dana B

Volltext